Rule out lymphoma panel pin

FLOW

Rule out lymphoma panel

Panel Components:
CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD19, CD20, CD34, CD38, CD45, CD56, kappa, lambda

Methodology: FLOW

Clinical Significance:
This two-tube assay includes one tube targeted primarily at mature B cells, and a second tube targeted primarily at mature T and NK cells. This panel is ideal for ruling out lymphoma in any type of fresh material. Both tubes contain nine antibodies (“9 colors”), with a tenth color allowing use of the DNA binding dye DAPI to facilitate exclusion of DAPI-positive dead and dying cells from the analysis. Antigens evaluated in the B cell tube include CD45, kappa, lambda, CD19, C5, CD20, CD10, CD56, and CD38. Antigens evaluated in the T cell tube include CD45, CD2, CD7, CD3, CD34, CD56, CD5, CD4, and CD8. Potential add-on tubes include:

• Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)/ mantle cell lymphoma (MCL) add-on tube
• Follicular lymphoma (FL)/Burkitt lymphoma (BL) add-on tubes
• Hairy cell leukemia/marginal zone lymphoma add-on tube
• CD5-negative B cell therapy add-on tube
• CD5-positive B cell therapy add-on tube
• Rule out plasma cell dyscrasia tube
• B cell versus plasma cell add-on tube
• T cell receptor add-on tube
• T cell therapy add-on tube
• Large T cell therapy add-on tubes
• B-ALL add-on tube
• T-ALL add-on tube

Organ: Blood/Bone Marrow, Body Fluids, Lymph Node / Spleen, Other tissue sites, Thymus (Mediastinal Mass)

Disease State: Anaplastic Large Cell Lymphoma (Systemic or Cutaneous), Angioimmunoblastic T Cell Lymphoma, B Cell NHL with Plasmacytoid Differentiation, B Cell Non-Hodgkin Lymphoma (not otherwise classified), Burkitt's Lymphoma, Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL), Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, HIV-Associated Lymphoma, Lymphoplasmacytic Lymphoma, Marginal Zone/MALT Lymphoma, NK/T Cell Lymphoma, Nasal Type, Peripheral T Cell Lymphoma, NOS (of Large Cell Type), Plasma Cell Myeloma/Neoplasm, Post-Transplant Lymphoproliferative Disorders, T Cell Non-Hodgkin Lymphoma (not otherwise classified)

CPT Code(s): 88184 x 1, 88185 x 14, 88188 x 1 (reference only; CPTs may vary)

Turnaround Time: Physician will be contacted by 9:00 PM PST the day of receipt for acute/life threatening conditions; next business day for routine flow cases.

Schedule: Monday-Saturday

Specimen Requirements:
• Peripheral blood, Preferred: 3 ml in sodium heparin (green top) / Acceptable: 3 ml in EDTA (purple top) - OR -
• Bone marrow aspirate, Preferred: 1-2 ml in sodium heparin (green top) / Acceptable: 1-2 ml in EDTA (purple top) - OR -
• Tissue: Finely minced tissue in RPMI transport media - OR -
• Body fluids: In RPMI transport media